Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactation induction by treatment-duration groups in non-pregnant intended mothers after surrogacy
IRCT20240522061869N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ethinyl estradiol + drospirenone and domperidone in hypogalactia (3 arms), sponsored by Tehran University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
ethinyl estradiol + drospirenonedomperidone
03
Conditions
hypogalactia
Beyond the preview
Go deeper on IRCT20240522061869N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240522061869N1.